{
  "url": "https://www.law.cornell.edu/regulations/new-york/18-NYCRR-512.1",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 18 ยง 512.1 - Scope, purpose and definitions",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 18 ยง 512.1 - Scope, purpose and definitions\n\nState Regulations\n(a) Scope. This Part sets forth the\nrequirements and procedures for the department's medical assistance (MA)\nprospective drug utilization review program. (b) Purpose. The purpose of the program is to\nidentify potential problems associated with MA recipient's drug therapy. The\nproblems which the program seeks to identify include, but are not limited to, over-utilization, interactions between and among drugs prescribed for an MA\nrecipient, therapeutic overlap and other drug therapy irregularities. Pharmacies which dispense drugs to MA recipients will have access to a central\ncomputerized drug utilization review system which screens ordered drugs against\nthe recipient's drug history file for potential drug therapy problems and\ninforms the pharmacist of identified problems before the pharmacist dispenses a\ndrug. The pharmacist will be able to evaluate this information and perform a\nprospective drug utilization review to determine whether or not, in the\npharmacist's professional judgement, therapeutic intervention as described in\nsection\n512.4\n(d) of this\n\nPart is necessary. (c) Definitions. Terms used in this Part have the same meaning as those defined in section\n505.3\nof this Title unless\notherwise specified. (1)\n\nProspective drug\nutilization review means a pharmacist's analysis of an MA recipient's drug use, based on established clinical standards for drug therapy, which is done at the\npoint of service before a drug is dispensed. (2)\n\nElectronic Medicaid eligibility\nverification system (EMEVS) means the department's on-line computerized system\nfor verification of an individual's eligibility for MA. (3)\n\nNational drug code (NDC) means the\nnumerical universal drug product code identifier which is assigned to a drug by\nthe Secretary of Health and Human Services pursuant to the Drug Listing Act of\n1972 ( P.L. 92-387). (4)\n\nPharmacy\nmeans any place meeting the definition contained in article 137 of the\n\nEducation Law and which is registered and licensed by the appropriate authority\nof the state in which the pharmacy is located. (5)\n\nPharmacist means a person licensed or\notherwise authorized to practice pharmacy by the appropriate authority of the\nstate in which the pharmacist practices. (6)\n\nDrug means both prescription and\nnonprescription drugs. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 18\nยง\n512.1\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 41715
}